Table 3 Contraception at six-weeks postpartum clinic excluding women who underwent postpartum female sterilization during the COVID-19 period (n = 3108)
Contraceptive method | COVID-19 period (n = 1490) | Historical cohort (n = 1618) | |||
|---|---|---|---|---|---|
| Â | n (%) | n (%) | |||
Combined oral contraceptive pills | 308 (20.67) | 359 (22.19) | |||
DMPAa | 162 (10.87) | 212 (13.10) | |||
Progesterone only pills | 143 (9.60) | 122 (7.54) | |||
Contraceptive Implant | 124 (8.32) | 149 (9.21) | |||
Copper IUDb | 4 (0.27) | 3 (0.19) | |||
LNG-IUSc | 3 (0.20) | 0 | |||
Male condoms | 350 (23.49) | 372 (22.99) | |||
Withdrawal | 48 (3.22) | 26 (1.61) | |||
Lactational amenorrhea | 1 (0.07) | 0 | |||
Fertility awareness method | 10 (0.67) | 21 (1.30) | |||
No contraception | 337 (22.62) | 354 (21.88) |